DR Reddys Laboratories Limited — Ras Exporter Profile
Indian Pharmaceutical Exporter · #14 for Ras · $2.1M export value · DGFT Verified
DR Reddys Laboratories Limited is the #14 Indian exporter of Ras with $2.1M in export value and 43 verified shipments. DR Reddys Laboratories Limited holds a 0.7% market share in Ras exports across 8 countries. The company exports 37 pharmaceutical products worth $62.4M across 17 therapeutic categories.
DR Reddys Laboratories Limited — Ras Export Profile: Buyers & Destinations
Where Does DR Reddys Laboratories Limited Export Ras?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $1.3M | 29 | 75.5% |
| BRAZIL | $200.0K | 4 | 11.4% |
| MALDIVES | $88.7K | 3 | 5.0% |
| JAMAICA | $50.0K | 1 | 2.8% |
| MAURITIUS | $39.4K | 2 | 2.2% |
| MALAYSIA | $37.8K | 2 | 2.1% |
| UNITED KINGDOM | $13.8K | 1 | 0.8% |
| FINLAND | $896 | 1 | 0.1% |
DR Reddys Laboratories Limited exports Ras to 8 countries. The largest destination is UNITED STATES accounting for 75.5% of DR Reddys Laboratories Limited's Ras shipments, followed by BRAZIL (11.4%) and MALDIVES (5.0%). These destinations reflect DR Reddys Laboratories Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Ras from DR Reddys Laboratories Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| DR REDDY SLABORATORIES INC | UNITED STATES | $502.1K | 11 |
| DR REDDYS LABORATORIES INC | UNITED STATES | $500.8K | 11 |
| NORTHSTAR DISTRIBUTION CENTER 8912 | UNITED STATES | $281.2K | 6 |
| CRISTALIA PRODUTOS QUIMICOS FARMACEUTICOS LIMITED | BRAZIL | $200.0K | 4 |
| STATE TRADING ORGANIZATION PLC | MALDIVES | $88.7K | 3 |
| T GEDDES GRANT DIST LIMITED | JAMAICA | $50.0K | 1 |
| NORTHSTAR DISTRIBUTION CENTER | UNITED STATES | $45.5K | 1 |
| DKSH MALAYSIA SDN BHD | MALAYSIA | $37.8K | 2 |
| HYPERPHARM LIMITED | MAURITIUS | $20.2K | 1 |
| HYPERPHARM LTD | MAURITIUS | $19.2K | 1 |
DR Reddys Laboratories Limited supplies Ras to 12 buyers globally. The largest buyer is DR REDDY SLABORATORIES INC (UNITED STATES), followed by DR REDDYS LABORATORIES INC (UNITED STATES) and NORTHSTAR DISTRIBUTION CENTER 8912 (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Ras Export Value and How Much Does DR Reddys Laboratories Limited Contribute?
India exported $123.4M worth of Ras through 15,000 shipments from 1156 suppliers to 176 countries, serving 2,323 buyers globally. DR Reddys Laboratories Limited contributes $2.1M to this total, accounting for 0.7% of India's Ras exports. DR Reddys Laboratories Limited ships Ras to 8 countries through 12 buyers.
What Is the Average Shipment Value for DR Reddys Laboratories Limited's Ras Exports?
DR Reddys Laboratories Limited's average Ras shipment value is $50.0K per consignment, based on 43 shipments totaling $2.1M. The largest destination is UNITED STATES (75.5% of DR Reddys Laboratories Limited's Ras exports).
How Does DR Reddys Laboratories Limited Compare to Other Indian Ras Exporters?
DR Reddys Laboratories Limited ranks #14 among 1156 Indian Ras exporters with a 0.7% market share. The top 3 exporters are INTAS PHARMACEUTICALS LIMITED ($36.5M), MSN LABORATORIES PRIVATE LIMITED ($22.3M), MYLAN LABORATORIES LIMITED ($20.1M). DR Reddys Laboratories Limited processed 43 shipments to 8 destination countries.
What Ras Formulations Does DR Reddys Laboratories Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| LURASIDONE HCL TAB 80MG 30S HDPE USA | $100.0K | 2 |
| LURASIDONE HYDROCHLORIDE TABLETS 120MG 15936 X 30S PACKS=478080 NOS | $50.0K | 1 |
| FILGRASTIM 300MCG GRAFEEL PFS QTY:1200 PACKS | $50.0K | 1 |
| 300015335 ZIPRASIDONE HYDROCHLORIDE CAPSULES 60MG 60S 20760*60=1245600 | $50.0K | 1 |
| 300015334 ZIPRASIDONE HYDROCHLORIDE CAPSULES 80MG 60S 34416 X 60=2064960 NOS | $50.0K | 1 |
| ZIPRASIDONE HYDROCHLORIDE CAPSULES 40MG60 S 24564 X 60 S PACKS= 1473840 NOS | $50.0K | 1 |
| ZIPRASIDONE HYDROCHLORIDE CAPSULES 80MG60 S 16992 X 60 S PACKS= 1019520 NOS | $50.0K | 1 |
| ZIPRASIDONE HCL CAPSULES 20MG 19508x60's PACK | $50.0K | 1 |
| ZIPRASIDONE HYDROCHLORIDE CAPSULES 20MG60S PACKS 39024 X 60S PACKS =2341440 NOS | $50.0K | 1 |
| 300015336 ZIPRASIDONE HYDROCHLORIDE CAPSULES 40MG 60S 24350 SU X 60=14,61,000 NOS | $50.0K | 1 |
DR Reddys Laboratories Limited exports 42 distinct Ras formulations including tablets, capsules, syrups, and combination drugs. The top formulation is LURASIDONE HCL TAB 80MG 30S HDPE USA with 2 shipments worth $100.0K.
Regulatory Requirements: Exporting Ras to Key Markets
What DR Reddys Laboratories Limited must comply with to export Ras to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Brazil — ANVISA
Approval Process
Generic registration under RDC 200/2017. ANVISA GMP inspection of Indian facility mandatory before approval.
Timeline: 12–24 months
GMP & Export Requirements
ANVISA GMP certificate (CBPF) for each manufacturing site; on-site inspection by ANVISA
Certificate of Pharmaceutical Product from CDSCO; Import Authorization via SISCOMEX
Note: ANVISA maintains active Indian pharma facility inspection program. Inspection backlog can extend timelines.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does DR Reddys Laboratories Limited Compare to Nearest Ras Exporters?
Exporters ranked immediately above and below #14 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 12 | MACLEODS PHARMACEUTICALS LTD | $3.2M | 64 | 9 | $50.0K |
| 11 | INTAS PHARMACEUTICALS LTD | $2.5M | 51 | 8 | $50.0K |
| 14 | DR REDDYS LABORATORIES LIMITED ★ | $2.1M | 43 | 8 | $50.0K |
| 9 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $2.1M | 42 | 6 | $50.0K |
| 15 | INDOCO REMEDIES LIMITED | $400.0K | 8 | 2 | $50.0K |
DR Reddys Laboratories Limited ranks #14 among 1156 Indian Ras exporters. Average shipment value of $50.0K compared to the market average of $106.8K. The closest competitors by value are MACLEODS PHARMACEUTICALS LTD and INTAS PHARMACEUTICALS LTD.
Which Indian Ports Ship Ras Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 1,417 | 9.4% |
| DELHI AIR CARGO ACC (INDEL4) | 1,335 | 8.9% |
| NHAVA SHEVA SEA (INNSA1) | 947 | 6.3% |
| SAHAR AIR | 935 | 6.2% |
| DELHI AIR | 709 | 4.7% |
| Bombay Air | 648 | 4.3% |
| AHEMDABAD AIR ACC (INAMD4) | 528 | 3.5% |
| TUTICORIN SEA (INTUT1) | 406 | 2.7% |
Geopolitical & Trade Policy Impact on DR Reddys Laboratories Limited's Ras Exports
The global pharmaceutical export landscape has been significantly influenced by recent geopolitical events. The 2026 Strait of Hormuz crisis, initiated by military conflicts involving the United States, Israel, and Iran, led to the effective halt of shipping traffic through this critical maritime route, disrupting approximately 20% of the world's daily oil supply and causing a surge in global energy prices. (en.wikipedia.org) This disruption has had a cascading effect on shipping costs and insurance premiums, directly impacting Indian pharmaceutical exporters like Dr. Reddy's, which rely on these routes for timely delivery of products to key markets.
Simultaneously, the 2025–26 United States–India diplomatic and trade crisis, marked by the imposition of a 50% tariff on Indian exports by the U.S., has posed additional challenges. These tariffs have increased the cost of Indian pharmaceutical products in the U.S. market, potentially affecting the competitiveness of companies like Dr. Reddy's. (en.wikipedia.org)
In the European Union, compliance with the Falsified Medicines Directive (FMD) remains a critical requirement for exporters. Dr. Reddy's has been proactive in adhering to these regulations, ensuring that its products meet the stringent safety and traceability standards mandated by the EU, thereby maintaining its market access and reputation.
DR Reddys Laboratories Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. Dr. Reddy's has demonstrated a commitment to quality by securing approvals from major regulatory bodies, including the U.S. Food and Drug Administration (FDA), the World Health Organization (WHO), and the European Medicines Agency (EMA). The company's recent Biologics License Application (BLA) submission for a proposed interchangeable biosimilar to Orencia® (abatacept) underscores its adherence to rigorous regulatory processes. (stockwatch.com)
However, the company has faced regulatory challenges, such as the tax audit decision from the Russian Federal Tax Service in January 2026, which reclassified certain marketing services as taxable, resulting in a penalty. (stocktitan.net) Such incidents highlight the complexities of operating in diverse regulatory environments and the importance of robust compliance frameworks.
About DR Reddys Laboratories Limited
DR Reddys Laboratories Limited exports 37 products worth $62.4M. Beyond Ras, top products include Omeprazole, Metoprolol, Diclofenac, Clopidogrel, Fexofenadine. View the complete DR Reddys Laboratories Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ras — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ras shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: DR Reddys Laboratories Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 43 individual customs records matching DR Reddys Laboratories Limited exporting Ras, covering 42 formulations to 8 countries via 12 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 176+ countries, 2,323+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ras Export Data from DR Reddys Laboratories Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for DR Reddys Laboratories Limited's Ras exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
DR Reddys Laboratories Limited
Full Company Profile →
37 products · $62.4M total trade · 17 categories
Ras Stats
Company Overview
Top Products by DR Reddys Laboratories Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for DR Reddys Laboratories Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ras. For current shipment-level data, contact TransData Nexus.